Johnson & Johnson Faces Pressure From U.S. Patent Office
February 13, 2015 at 11:18 AM EST
Morgan Stanley analysts David Lewis and Scott Wang reviewed Johnson & Johnson (NYSE: JNJ) after the US patent office rejected its 2018 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.